Qepler | summits & conferences | 2nd Annual Pre-Filled Syringes Summit, Barcelona, 04-05 June 2019
Event Location:
Barcelona, Spain
Hotel H10 Marina Barcelona Av. Bogatell, 64-68
04 June 2019 - 05 June 2019
Contact Person: Evgenia Makar
Contact Person: Evgenia Makar, Qepler s.r.o.
Contact Person: Denis Polikarpov
Contact Person: Denis Polikarpov, Qepler s.r.o.

Conference Overview

The global pre-filled syringes market witnesses an exponential growth owing to the increasing prevalence of chronic diseases and the demand for self-administered drugs.

Today’s patient looks for simplicity, personalization and instant connectivity, when it comes to self-administered injections.

In parallel, the evolution of biologic parenterals creates unique demands and challenges for the development of a custom drug delivery device.

The featured talks on:

  • The need for integrated development approach. Interface between drug, device and patient.
  • Involving patients into device development program. Translating user needs and capabilities into design inputs.
  • Measuring device usability. Integrating human factors into clinical studies.
  • Perfect employee experience model: rethinking the roles, structure, tools, and strategies to design and deliver an integrated employee experience.
  • Device selection process for a biologic drug. Ensuring compatibility and performance.
  • Designing syringe able biopharmaceuticals. Factors affecting stability.
  • Mixing in liquid/liquid and lyophilized/liquid formulations.
  • Materials selection for next generation PFS. Supply chain control.
  • Extractables and leachables considerations for PFS.
  • Handling glass primary containers. Reducing tungsten residues. Screening for glass breakage.
  • PFS filling and stoppering challenges. A pharma perspective.
  • Assembly of syringes into devices. Needle bonding and adhesives.
  • Integrity testing of PFS.

Meet our Speakers

Our Sponsors

Speaker Sponsor
Intertek (Schweiz) AG
Exhibition Booth Sponsor
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care.



Harshal Shah

Cambridge Consultants

chaired a panel discussion on the digitisation of clinical trials and next gen injectable devices, with speakers from Novartis, Roche, Janssen, Sanofi, SHL Group and Corvus Device.